Skip to main content

Table 4 Cox analyses for recurrent ischemic stroke

From: Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study

Variables

Univariate analyses

Multivariate analyses

HR (95%CI)

P Value

HR (95%CI)

P Value

Age

1.044 (0.978–1.114)

0.199

  

Sex

5.645 (0.658–48.423)

0.115

  

BMI

1.109 (0.959–1.283)

0.163

0.954 (0.747–1.219)

0.708

Smoking

2.390 (0.437–13.068)

0.315

  

Hypertension

4.092 (0.749–22.351)

0.104

1.614 (0.209–12.480)

0.647

Hypercholesterolemia

7.349 (1.481–36.472)

0.015*

41.826 (2.188-799.396)

0.013*

Diabetes

25.648 (2.993–219.82)

0.003*

26.938 (1.779–407.820)

0.018*

Primary symptom (%)

    

 Infarction

1.568 (0.316–7.771)

0.582

  

 Non-infarction

Reference

-

  

Laboratory results

    

 WBC count, 109/L

1.483 (1.203–1.828)

< 0.05*

  

 LY count, 109/L

0.863 (0.254–2.928)

0.813

  

 PLT count, 109/L

1.007 (0.998–1.016)

0.114

  

 Cr, µmol/L

1.038 (0.995–1.083)

0.085

  

 UA, µmol/L

0.999 (0.991–1.008)

0.859

  

 ALT, U/L

1.016 (0.991–1.042)

0.212

  

 HDL, mmol/L

0.247 (0.015–4.063)

0.328

1.259 (0.080-19.715)

0.870

 LDL, mmol/L

0.639 (0.221–1.849)

0.409

  

 TG, mmol/L

1.505 (0.723–3.133)

0.274

  

 TC, mmol/L

0.586 (0.234–1.470)

0.255

  

 GGT, mmol/L

0.996 (0.952–1.041)

0.844

0.930 (0.834–1.036)

0.185

 HCY, µmol/L

1.037 (0.958–1.122)

0.370

  

 ApoA, g/L

0.783 (0.043–14.230)

0.869

  

 ApoB, g/L

0.42 (0.009–21.294)

0.669

  

Suzuki stage, n (%)

    

 1–3

Reference

-

  

 4–6

0.994 (0.465–2.124)

0.987

  

Surgical option (%)

    

 Indirect bypass

Reference

-

Reference

-

 Direct bypass

0.561 (0.103–3.065)

0.505

0.048 (0.002–1.113)

0.058

NAFLD

8.066 (1.474–44.134)

0.016*

10.815 (1.259–92.881)

0.030*

  1. HR, Hazard Ratio; CI, confidence interval; * P < 0.05, significant difference